Trial intelligence / Profile preview

Ibuprofen Injection for Fever

CTR20150623Phase 3Active

Sponsor
Tianjin Hankang Pharmaceutical Biotechnology
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibuprofen in fever, sponsored by Tianjin Hankang Pharmaceutical Biotechnology. Started Apr 2016; status: active.

02

Drugs

ibuprofen
03

Conditions

fever

Beyond the preview

Go deeper on CTR20150623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call